Effect of Laser in Treatment of Vulval Warts NCT03830047

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Recruiting

Vulval warts is a magor problem that affects women .

The causative organism for vulval warts is human papilloma virus There are many treatment modalities that can trat these warts

Recruitment information / eligibility
Status	Recruiting
Enrollment	40
Est. completion date	November 20, 2019
Est. primary completion date	October 15, 2019
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	Female
Age group	18 Years to 40 Years
Eligibility	Inclusion Criteria: - women who have vulval warts - Age between 18- 40 years Exclusion Criteria: - warts that were previously treated by surgery or cryotherapy

Device:
• nd yag laser
nd yag laser will be applied on the vulval warts

Locations
Country	Name	City
Egypt	Algazeerah	Giza
Egypt	Algazeerah and Kasralainy hospital	Giza
Egypt	Aljazeera( Al Gazeera) hospital	Giza

Sponsors *(2)*
Lead Sponsor	Collaborator
Aljazeera Hospital	National Research Center, Egypt

Egypt,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	The number of women who will be completely cured by laser beam	how laser will cure the warts	within 2 months